reviewThe LancetMay 1, 2007Closed access

Inflammatory bowel disease: clinical aspects and established and evolving therapies

DCDaniel C. BaumgartWJWilliam J. Sandborn

Charité - Universitätsmedizin Berlin · Humboldt-Universität zu Berlin · +1 more institution

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

1,927
total citations
FWCI
57.27
Percentile
100%
References
167
Citations per year

Authors

2

Topics & keywords

Topics
Keywords
  • Medicine
  • Natalizumab
  • Certolizumab pegol
  • Adalimumab
  • Infliximab
  • Inflammatory bowel disease
  • Ulcerative colitis
  • Immunology
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.